Site Map
Pages
Pipeline Programs
- FORTIFIDE: Gemcitabine/Nab-paclitaxel + continuous infusion of certepetide or placebo | United States
- iGoLSTA: Nivolumab/FOLFIRINOX + certepetide | Australia
- Phase 2b: Gemcitabine/Nab-paclitaxel + certepetide | China
- Temozolomide with certepetide or placebo | Estonia/Latvia
- iLSTA: Gemcitabine/Nab-paclitaxel/Durvalumab + certepetide | Australia
- XOWNA® (LSTA16) (U.S.)
- HONEDRA® (LSTA12) (Japan)
- LSTA201 (U.S.)
- No-Option Refractory Disabling Angina